David Brancaccio

And what's good for patients isn't good for stockholders of Novo Nordisk, the Denmark-based company behind the weight loss drug Wagovi.

The firm warned today of, quote, unprecedented downward pressure on prices for weight loss drugs.

And the stock is down 17 percent in Copenhagen now.

I'm David Brancaccio, Marketplace Morning Report from APM, American Public Media.

A key question for market players, what would Kevin do?

I'm David Brancaccio in Los Angeles.

Good morning to you.

Investors are trying to figure out what kind of federal reserve we would see under Kevin Warsh, President Trump's nominee.

Would the central bank stay independent?

Is Warsh really an inflation dove as advertised?

Marketplace's Nancy Marshall-Genza reports.

Venezuela's acting president, Delcy Rodriguez, signed a law last week opening the oil industry there to private ownership, a reversal for a sector that's been state-run for about 20 years.

Now, this was a key demand of the Trump administration since the U.S.

military attack in Caracas to seize Venezuela's president, Nicolas Maduro.

The BBC's Norberto Paredes has a report now from Venezuela's oil country.

Norberto Paredes is with our newsroom partners, the BBC.

And stock in the big data government contractor Palantir is up 5% now after its profits and revenue for last quarter beat expectations.

Sales up 70% from a year earlier.

The Pentagon has embraced Palantir's offerings, but some Palantir employees and elected officials are criticizing the company's work to track immigrants for deportation.

The company's co-founder, Alex Karp, said last year his company has zero competition.